SIA Pharma NordActive

40003501290Limited liability companyFounded 2000

Key figures

455 248 €+28,3%
Revenue 2025
-2,2%
Average annual change 2010–2025
0250 k500 k750 k1 m’10’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Ratios

2025
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
0250 k500 k750 k’10’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Dividends

calculated
2025

Paid out in dividends approximately 6000 € (20% of equity at the end of the previous year).

Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).

History
2025 ~6000 €
2024 ~29 000 €
2023 ~13 000 €
2022 ~12 000 €
2021 ~24 999 €
20200 €
2019 ~170 639 €
20180 €
20170 €
20160 €
20150 €
20140 €
20130 €
20120 €
20100 €
Summary of financial statements2010–2025
201020122013201420152016201720182019202020212022202320242025
Balance sheet — assets
Total current assets218 387290 226310 702575 311663 385189 862186 083218 972240 795249 689252 169261 893386 720417 862270 251
Total non-current assets13 21116 2409756807332 28827 33522 83316538634108333475341520491256
Total assets231 598306 466320 458583 384695 673217 197208 916220 625241 658250 099253 002265 368390 135419 911271 507
Balance sheet — liabilities and equity
Current liabilities135 623221 254168 015448 720528 15238 74725 00425 523202 416198 145216 449228 178337 175389 562233 406
Non-current liabilities40 60040 80077 985000000000000
Total liabilities176 223262 054246 000448 720528 15238 74725 00425 523202 416198 145216 449228 178337 175389 562233 406
Share capital———————————————
Retained earnings of previous periods———————————————
Profit for the year-40 19023 77221 70531 00934 11117 758596211 19014 77912 712959813 63728 770638913 752
Total equity55 37544 41266 115125 081159 192176 950182 912194 10238 24250 95435 55337 19052 96030 34938 101
Income statement
Sales revenue620 977619 537552 263775 898830 141585 998270 475241 154287 157397 617316 966335 306442 819354 932455 248
Operating profit-35 30531 99230 02542 74547 27727 497877112 60014 76312 96916 54517 35732 36414 57024 669
Profit before income tax-40 19028 72727 80238 35241 25229 045596211 51714 83412 76215 84816 76632 15414 52224 665
Profit for the reporting year-40 19023 77221 70531 00934 11117 758596211 19014 77912 712959813 63728 770638913 752
Labour costs———————————————
Depreciation of non-current assets———————————————
Other indicators
Employees1212129912445555544
Calculated dividend00000000170 639024 99912 00013 00029 0006000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph
100%SIA Pharma NordPHARMA NORD ApSWallin EliSvarrer Michael Maul
CompanyPersonShareholderOther roleAdditional link

Summary: SIA Pharma Nord

Overview

SIA Pharma Nord (reg. no. 40003501290) is a limited liability company. The company was registered in 2000 and has been in the register for 26 years. Registered address: Rīga, Kleistu iela 24.

Financial results

Revenue in 2025 was 455 248 €, up 28,3% on the previous year (354 932 €). From 2010 to 2025, revenue declined by an average of 2,2% per year. Net profit for 2025 was 13 752 € (3,0% of revenue). The company was profitable in 14 of the 15 published years. In 2025 the company had 4 employees. Revenue per employee was 113 812 €. At the end of 2025, total assets were 271 507 € and equity 38 101 € (14,0% of assets).

Management and owners

The board has 2 members. The sole owner of the company is PHARMA NORD ApS.

Data sources and freshness

Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.